Cargando…

A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common inherited monogenic disorders, characterized by a progressive decline in kidney function due in part to the formation of fluid-filled cysts. While there is one FDA-approved therapy, it is associated with potential adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asawa, Rosita R., Danchik, Carina, Zakharov, Alexey, Chen, Yuchi, Voss, Ty, Jadhav, Ajit, Wallace, Darren P., Trott, Josephine F., Weiss, Robert H., Simeonov, Anton, Martinez, Natalia J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060218/ https://www.ncbi.nlm.nih.gov/pubmed/32144367 http://dx.doi.org/10.1038/s41598-020-61082-3

Ejemplares similares

Author Correction: A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells
por: Asawa, Rosita R., et al.
Publicado: (2022)

Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Carrera, Paola, et al.
Publicado: (2016)

Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing
por: Shen, Min, et al.
Publicado: (2017)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

Association of PKD1 sequence variants with pathophysiology of ADPKD in Indian patients
por: Raj, Sonam, et al.
Publicado: (2014)

Identification of ADPKD-Related Genes and Pathways in Cells Overexpressing PKD2
por: Zhang, Zhe, et al.
Publicado: (2020)

More dissimilarities than affinities between DNAJB11-PKD and ADPKD
por: Pisani, Isabella, et al.
Publicado: (2022)

PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model
por: Wang, Runming, et al.
Publicado: (2022)

Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD
por: Rogers, Kelly A., et al.
Publicado: (2016)

Correction to: PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model
por: Wang, Runming, et al.
Publicado: (2022)

PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression
por: Lakhia, Ronak, et al.
Publicado: (2022)

Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
por: Suwabe, Tatsuya, et al.
Publicado: (2013)

Evidence of a third ADPKD locus is not supported by reanalysis of designated PKD3 families
por: Paul, Binu M., et al.
Publicado: (2013)

RNA helicase p68 inhibits the transcription and post-transcription of Pkd1 in ADPKD
por: Zhang, Lu, et al.
Publicado: (2020)

Atypical splicing variants in PKD1 explain most undiagnosed typical familial ADPKD
por: Hort, Yvonne, et al.
Publicado: (2023)

Cure of ADPKD by Selection for Spontaneous Genetic Repair Events in Pkd1-Mutated iPS Cells
por: Cheng, Li-Tao, et al.
Publicado: (2012)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants
por: Hallows, Kenneth R., et al.
Publicado: (2022)

PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease
por: Vouk, Katja, et al.
Publicado: (2006)

Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations
por: Losekoot, Monique, et al.
Publicado: (2020)

Incoercible Vomiting in a Polycystic (ADPKD) Patient on Peritoneal Dialysis
por: Burguera Vion, Victor, et al.
Publicado: (2021)

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
por: McEwan, Phil, et al.
Publicado: (2018)

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease
por: Choi, Rihwa, et al.
Publicado: (2014)

PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies
por: Steele, Cortney, et al.
Publicado: (2021)

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts
por: Moyes, S, et al.
Publicado: (2012)

ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies
por: Bergmann, Carsten
Publicado: (2014)

Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
por: Pfeferman, Mariana Becker, et al.
Publicado: (2022)

Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease
por: Liu, Bei, et al.
Publicado: (2015)

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course
por: Kim, Kyoungmi, et al.
Publicado: (2019)

Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing
por: Trujillano, Daniel, et al.
Publicado: (2014)

Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease
por: Liu, Bei, et al.
Publicado: (2016)

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
por: Wilk, Elizabeth J., et al.
Publicado: (2023)

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
por: Harris, Tess, et al.
Publicado: (2018)

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2020)

A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity
por: Yasgar, Adam, et al.
Publicado: (2017)

Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity
por: Yasgar, Adam, et al.
Publicado: (2018)

Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
por: McBride, Lucy, et al.
Publicado: (2020)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD
por: Perrone, Ronald D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pq0ob3dd4lnl39bjhf3q6mq4ce